Government Cloud Authors: Elizabeth White, Pat Romanski, Dana Gardner, Liz McMillan, Gopala Krishna Behara

Related Topics: Government Cloud

News Feed Item

Bio-IT World Announces Winners of Its 2008 Best Practices Awards

Editor's Choice Award Goes to Dr. Kenneth H. Buetow, Ph.D., The National Cancer Institute Center for Biomedical Informatics and

NEEDHAM, MA -- (MARKET WIRE) -- 04/30/08 -- Bio-IT World magazine today announced the winners of its fourth Best Practices Awards program. Grand Prize winners within seven life sciences awards categories include Applied Biosystems, Christian-Albrechts-University, Eli Lilly & Company, GlaxoSmithKline, Genstruct, Sirtris Pharmaceuticals, AstraZeneca, and Merck & Company.

Established in 2003, Bio-IT World's Best Practices Awards Program recognizes these organizations for their outstanding innovations and excellence in the use of technologies, practices, and novel business strategies that will advance drug discovery, development, biomedical research, and clinical trials. In addition, this year's recipient of the Editor's Choice Award is Dr. Kenneth H. Buetow, NCI Associate Director for Bioinformatics and Information Technology, for the implementation of caBIG, an open source network to speed cancer research.

Bio-IT World's Best Practices Awards ceremony was held last night at the World Trade Center in Boston, MA, co-located with CHI's Sixth Annual Bio-IT World Conference & Expo. Key industry leaders attended the ceremony, which featured keynote speeches by Colin Hill, CEO, president, chairman & co-Founder of Gene Network Sciences; and Dietrich Stephan, Ph.D., co-founder and chief science officer of Navigenics, former deputy director, Translational Genomics Research Institute.

Phillips Kuhl, co-founder and president of Cambridge Healthtech Institute (CHI), started the evening with welcoming comments and introduced Kevin Davies, Ph.D., editor-in-chief of Bio-IT World, the flagship publication of CHI, to initiate the presentation of awards.

"Bio-IT World salutes the winners of its 2008 Best Practices Awards program. Not only have they demonstrated impressive technical achievements as judged by their peers, but also they've demonstrated a commitment to advancing 'best practices' throughout the biomedical research and drug development community by their willingness to share information about the innovative tools they are using and explaining how they use them," said Kevin Davies, editor-in-chief of Bio-IT World.

A peer-review panel of 14 expert judges reviewed 54 detailed submissions from organizations ranging from large pharmaceutical and biotechnology companies, academic institutions, to niche service providers, detailing best practices in one of seven categories. John Russell, executive editor of Bio-IT World; Rudy Potenzone, Ph.D., WW industry technology strategist for pharmaceuticals of Microsoft; James Reaney, director, research markets of BlueArc Corporation; and Kevin Davies, Bio-IT World, presented the Grand Prize trophies to the following organizations within these categories:

--  Basic Research, R&D:  Christian-Albrechts-University and
    Applied Biosystems
    These organizations were recognized for developing a pipeline to use
    for the identification of common susceptibility variants of functional
    significance for complex diseases, notably Crohn's disease.

--  Clinical Research:  Eli Lilly & Company
    The organization was recognized for managing and tracking metrics
    associated with implementing the SAS Drug Development
    solution / partnership.

--  Clinical Trials:  GlaxoSmithKline
    GSK was recognized for developing a novel industry capability which
    enables robust and efficient safety signal detection in clinical trials
    from phase 1 onward.

--  Drug Discovery & Development:  Genstruct and Sirtris Pharmaceuticals
    Both organizations were recognized for developing a Casual Network
    Modeling (CNM) system -- a powerful approach to modeling complex
    biological systems. Sirtris and Genstruct collaborated to characterize
    the molecular MOA of a revolutionary set of bioactive, Sirt1 --
    activating small molecules.

--  IT Informatics:  AstraZeneca Pharmaceuticals
    The organization was recognized for implementing the FDA's electronic
    submissions gateway with SAFE digital signatures.

--  Knowledge Management:  AstraZeneca Discovery (UK)
    The organization was recognized for standardizing screening data
    globally and making it available to all AstraZeneca sites.

--  Translational and Personalized Medicine:  Merck & Company
    The organization was recognized for breaking down clinical and research
    silos that allowed them to view the Biomarker Information Pipeline with
    the Moffitt Cancer Center that automates the flow and integration of
    patient care data and gene expression data.

Honorable recognition also went to the following organizations in the seven categories:

--  Basic Research, R&D:  University of Pittsburgh Cancer Institute
--  Clinical Research:  National Institute of Neurological Disorders &
--  Clinical Trials:  Johnson & Johnson PRD Early Development
--  Drug Discovery & Development:  GlaxoSmithKline
--  IT Informatics:  River Road Bio
--  Knowledge Management:  Naval Medical Research Center
--  Translational and Personalized Medicine:  Cogenics

Criteria and Judging

Awards finalists and winners were selected for their innovative utilization of bio-IT, including life science equipment, informatics and information technology, on a project or organizational level to achieve significantly improved results (i.e. improvements in productivity or conceptual breakthroughs in scientific understanding or process methodology). The peer review judges applied several criteria to make their decisions, such as innovation, significance, and industry impact. Entries were accepted from R&D and scientific facilities and labs in pharmaceutical companies, biotech companies, academia, government, medical or related institutions and organizations, as well as public and private research labs. For information on Bio-IT World's 2008 Best Practices Awards, please email [email protected]. The July/August issue of Bio-IT World will feature editorial on Best Practices, highlighting award winners, profiling entrants, event coverage and the enabling technologies used by the many companies.

The 2008 Best Practices Awards were organized by Bio-IT World editors, including Executive Editor John Russell, Associate Managing Editor Allison Byrum Proffitt, Editor-in-Chief Kevin Davies, and key marketing & operations staff members of Cambridge Healthtech Media Group, a division of CHI. Joining the editors in judging the entries was a distinguished panel of experts, including:

--  Stephen Fogelson, Devolotron
--  Jim Golden, SAIC
--  Stan Kachnowski, Mailman School of Public Health, Columbia University
--  Jerry Schindler, Merck
--  Deborah Borfitz, Contributing Editor, eCliniqua
--  Sandy Aronson, Harvard Medical School
--  Howard Asher, LSIT
--  Susie Stephens, Eli Lilly
--  Susan Ward, Consultant
--  John Whittle, Tessella
--  Chris Connor, Health Industry Insights
--  Phillips Kuhl, Cambridge Healthtech Institute


Sponsors generously underwriting the 2008 Best Practices Awards are Microsoft and BlueArc Corporation.

The winners will be profiled in the July/August issue of Bio-IT World.

The 2009 Bio-IT World Best Practices competition will begin soliciting entries in October 2008.

About Bio-IT World

Bio-IT World (www.bio-itworld.com), the flagship publication of Cambridge Healthtech Institute (CHI), is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials. Bio-IT World explores the tools and results of predictive biology as the industry adapts to the new world of personalized medicine. Bio-IT World has won 34 national and regional awards, more than any other magazine covering the life sciences industry. CHI offers a suite of published resources through a new division -- Cambridge Healthtech Media Group -- that includes Bio-IT World magazine, numerous topic-specific eNewsletters, white papers, webcasts, podcasts, conferences, and the Bio-IT World Best Practices Awards. The magazine is based in Needham, MA.

About Cambridge Healthtech Institute (CHI)

Founded in 1992, Cambridge Healthtech Institute (www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, academic, and niche service provider organizations. CHI's integrated life science portfolio of products and services includes Cambridge Healthtech Institute Conferences, Pharmaceutical Strategy Series, Barnett International, Insight Pharma Reports, Marketing Services, Meeting Planners, and Cambridge Healthtech Media Group, which includes numerous eNewsletters, Bio-IT World magazine, as well as Lead Generation Programs.

Kevin Davies
(Editor-in-Chief, Bio-IT World)
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

IoT & Smart Cities Stories
Nicolas Fierro is CEO of MIMIR Blockchain Solutions. He is a programmer, technologist, and operations dev who has worked with Ethereum and blockchain since 2014. His knowledge in blockchain dates to when he performed dev ops services to the Ethereum Foundation as one the privileged few developers to work with the original core team in Switzerland.
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
Dynatrace is an application performance management software company with products for the information technology departments and digital business owners of medium and large businesses. Building the Future of Monitoring with Artificial Intelligence. Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more busine...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science," is responsible for setting the strategy and defining the Big Data service offerings and capabilities for EMC Global Services Big Data Practice. As the CTO for the Big Data Practice, he is responsible for working with organizations to help them identify where and how to start their big data journeys. He's written several white papers, is an avid blogge...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settlement products to hedge funds and investment banks. After, he co-founded a revenue cycle management company where he learned about Bitcoin and eventually Ethereal. Andrew's role at ConsenSys Enterprise is a mul...
Whenever a new technology hits the high points of hype, everyone starts talking about it like it will solve all their business problems. Blockchain is one of those technologies. According to Gartner's latest report on the hype cycle of emerging technologies, blockchain has just passed the peak of their hype cycle curve. If you read the news articles about it, one would think it has taken over the technology world. No disruptive technology is without its challenges and potential impediments t...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of San...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...